O. Pagani

Discipline

Psychologie (1)

Type de document

Articles (4) Colloques et conférences (1)

Co-auteur

Date

Source

Mot-clé

procès (4) cancer (4) Treatment (4) Cancer (4) Patients (4) Cancer (4) Breast (4) Patients (4) thérapie (3) Methods (3) Trials (3) Therapeutics (3) Human beings (3) Older people (3) Methods (3) temps (durée) (2) norme (2) risque (2) analyse (2) dose (2) dosage (2) maladie (2) âge (2) survie (2) Development (2) Chemotherapy (2) Control (2) Trastuzumab (2) Aromatase (2) Ci (Chinese poetry) (2)

Documents écrit par O. Pagani (5) | parle de O. Pagani (0)

Management and Outcome of Young Women (≤40 Years) with Breast Cancer in Switzerland.
G. Montagna et al. (4 mars 2022)
Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data.
S. Schmid et al. (10 sept. 2019)
Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07).
K. Zaman et al. (2012)
Can resistance to trastuzumab be reversed by endocrine therapy? Combination of trastuzumab and letrozole after resistance to sequential trastuzumab and aromatase inhibitor monotherapies in patients with ER-positive, HER-2 positive, advanced breast cancer: a proof-of-concept trial (SAKK 23/03)
D. Koeberle et al. (2010)
Ventricular arrhythmia and torsade de pointe: dose limiting toxicities of the MDR-modulator S9788 in a phase I trial.
R. Stupp et al. (1998)